Invasive fungal infections in patients receiving intensive cytotoxic therapy for cancer
Empirical therapy of infections in neutropenic patients
The appropriate use of platelets
Treatment of haemophilia
Management of disseminated intravascular coagulation
Hyperhomocysteinemia is a risk factor for venous and arterial thrombosis
DERIVATION OF FUNCTIONAL DENDRITIC CELLS FROM BLAST CELLS IN ACUTE LEUKAEMIA
SUBVERSION OF CELL-MEDIATED IMMUNITY BY LEUKAEMIC CELLS
ABNORMALITIES OF MSH2 PROTEIN EXPRESSION ARE ASSOCIATED WITH P53 MUTATIONS IN ADULT LEUKAEMIA
MULTIPLEX PCR FOR THE DETECTION OF PROGNOSTICALLY IMPORTANT GENE REARRANGEMENTS IN ACUTE MYELOID LEUKAEMIA
MUTANT N-RAS BLOCKS GRANULOCYTIC DIFFERENTIATION OF HUMAN CD34+ CELLS
SUB-CELLULAR DISTRIBUTION AND RE-DISTRIBUTION OF BCL-2 FAMILY PROTEINS IN HUMAN T-LYMPHOBLASTIC LEUKAEMIC CELLS
THE PROTO-ONCOGENE FUS IS DOWN REGULATED WITHIN ONE HOUR OF ATRA TREATMENT OF HL60 CELLS
ETV6 IS FUSED WITH THE CAUDAL-RELATED HOMEOBOX GENE CDX2 IN A PATIENT WITH AML AND A t(12;13)(p13;q12)
DENDRITIC CELLS CULTURED FROM MONONUCLEAR CELLS AND CD34 CELLS IN MYELOMA DO NOT HARBOUR HUMAN HERPESVIRUS 8
SEROPREVALENCE OF KAPOSI'S SARCOMA ASSOCIATED HERPESVIRUS (KSHV/HHV-8) IN PATIENTS WITH MULTIPLE MYELOMA
PROLIFERATIVE MYELOMA PLASMA CELLS ARE AT THE LATEST STAGE OF DIFFERENTIATION
GENETIC CHANGES IN ATYPICAL CHRONIC LYMPHOCYTIC LEUKEMIA
ANALYSIS OF CHRONIC LYMPHOCYTIC LEUKAEMIA BY COMPARATIVE GENOMIC HYBRIDISATION
TWO CANDIDATE TUMOUR SUPPRESSOR GENES ON CHROMOSOME 13Q14, FREQUENTLY DELETED IN CHRONIC LYMPHOCYTIC LEUKAEMIA
HIGH MORTALITY OF DiSC ASSAY-RESISTANT CLL PATIENTS TREATED WITH FLUDARABINE
CHRONIC LYMPHOPROLIFERATIVE DISEASE ASSOCIATED WITH INTERSTITIAL 11Q (-)
HAEMOCHROMATOSIS MUTATIONS AND IRON STORES IN PREGNANCY
THE GENETIC COMPLEXITY OF HAEMOCHROMATOSIS IN NE SCOTLAND
THE EFFECT OF NATURAL AND INDUCED MUTATIONS AT THE DIMER INTERFACE OF HUMAN G6PD
THE CONTRIBUTION OF CD47 AND LW GLYCOPROTEIN (ICAM-4) TO THE BINDING OF SICKLED ERYTHROCYTES TO CULTURED ENDOTHELIUM
THE ROLE OF THE SPI POLYMORPHISM IN THE DEVELOPMENT OF OSTEOPOROSIS IN PATIENTS WITH THALASSAEMIA MAJOR
FUNCTIONAL ROLE OF POLYMORPHIC ENHANCER ELEMENTS ON FETAL HAEMOGLOBIN EXPRESSION IN SICKLE CELL ANAEMIA
INTRACELLULAR CYTOKINE DETECTION BY FLOW CYTOMETRY
A NOVEL ELISA BASED TECHNIQUE FOR THE DETECTION OF THE FACTOR V LEIDEN (FVL) MUTATION
NUCLEAR LOCALISATION OF HAEMOPOIETIC SERPIN 2A
INCIDENCE OF TRISOMY 3 AND P53 DELETIONS IN SPLENIC LYMPHOMA WITH VILLOUS LYMPHOCYTES. A STUDY BY FISH
PENETRANCE OF THE HLA-H (HFE) HOMOZYGOUS 845A GENOTYPE
UP-REGULATION OF HUMAN TELOMERASE CATALYTIC SUBUNIT GENE HTRT CORRELATES WITH ELEVATED TELOMERASE ACTIVITY IN HUMAN ACUTE MYELOID LEUKAEMIAS
MARKEDLY REDUCED EXPRESSION OF THE THROMBOPOIETIN RECEPTOR MPL IN PLATELETS FROM PATIENTS WITH MONOCLONAL AND POLYCLONAL ESSENTIAL THROMBOCYTHAEMIA
C-KIT MUTATIONAL ANALYSIS IN ACUTE AND CHRONIC MYELOPROLIFERATIVE DISORDERS
IMPROVED ENGRAFTMENT KINETICS BUT INCREASED CHRONIC GVHD IN UNMANIPULATED ALLOGENEIC SIBLING PBSC TRANSPLANTATION
REDUCED BONE MINERAL DENSITY (BMD) IN MALES AND FEMALES AFTER BONE MARROW TRANSPLANT (BMT)
CLINICAL RISK FACTORS AND THROMBOPHILIC ABNORMALITIES IN CHILDHOOD STROKE
IDENTIFICATION OF AML1-MTG8 FUSION TRANSCRIPT LEVELS IN BM AND PB SAMPLES THAT COULD DISTINGUISH PATIENTS IN STABLE REMISSION FROM THOSE AT RISK OF RELAPSE IN t(8;21) AML
PARP ACTIVATION IS INVOLVED IN DRUG AND FAS-INDUCED APOPTOSIS IN LEUKAEMIC CELLS
RECOMBINANT URATE OXIDASE (SR 29142) TO PREVENT HYPERURICAEMIA DURING CHEMOTHERAPY FOR HAEMATOLOGICAL MALIGNANCIES
A PILOT STUDY OF ORAL IDARUBICIN AND ETOPOSIDE IN ELDERLY PATIENTS WITH AML
CENTRAL ROLE OF SOLUBLE IMMUNOSUPPRESSIVE FACTORS IN THE DEVELOPMENT OF LEUKAEMIA-ASSOCIATED IMMUNE DYSFUNCTION
RAPID DETECTION OF BCR/ABL AND PML/RARA USING FLUORESCENCE IN-SITU HYBRIDISATION ON CYTOSPIN PREPARATIONS
LATE RELAPSING CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA
EVIDENCE THAT AN HLA-DQA1/DQB1 HAPLOTYPE INFLUENCES SUSCEPTIBILITY TO CHILDHOOD COMMON ALL PROVIDES FURTHER SUPPORT FOR AN INFECTION-RELATED AETIOLOGY
TWO CASES OF t(15;17) NOT ASSOCIATED WITH APL AND THE VALUE OF MOLECULAR SCREENING FOR PML/RAR alpha IN AML
COMPARISON OF FUNCTIONAL DIFFERENCES IN HAEMOPOIETIC GROWTH FACTOR RECEPTORS IN DE NOVO AND SECONDARY AML
DIRECT TESTING IN SMALL VOLUME BONE MARROW SAMPLES OF DNA EXCISION REPAIR IN RESPONSE TO EXPERIMENTAL DNA DIRECTED DRUG MOIETY EXPOSURE USING HIGH RESOLUTION CONFOCAL LASER SCANNING MICROSCOPY
PERSISTENCE OF CELL CYCLING RELATED ANTIGENS DURING APOPTOSIS DEMONSTRATED IN CHILDHOOD ALL
SYNERGY OF ATRA AND MUTANT RAS IN INDUCTION OF APOPTOSIS AND DIFFERENTIATION IN MYELOID LEUKAEMIA CELLS
CLONAL DIVERSITY OF IG AND TCR GENE REARRANGEMENTS IDENTIFIES A SUBSET OF CHILDHOOD B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA WITH INCREASED RISK OF RELAPSE
EARLY ALLOGENEIC TRANSPLANTATION FOR RESISTANT OR RELAPSED ACUTE LEUKAEMIA FOLLOWING REMISSION INDUCTION WITH FLAG
A NOVEL BLOCK BETWEEN CYTOCHROME C AND CPP32 RESULTS IN RESISTANCE TO APOPTOSIS IN LEUKAEMIC CELLS
Reproducible flow cytometric methodology for measuring multidrug resistance in AML blasts
THE IDENTIFICATION OF A RETINOIC ACID RESPONSIVE ALDO-KETO-REDUCTASE EXPRESSED DURING NEUTROPHIL AND MONOCYTE DIFFERENTIATION OF HL60 CELLS
MITOCHONDRIAL INHIBITORS MAY ACT AS PROMOTERS OF DIFFERENTIATION IN THE SERUM FREE HL60 CELL LINE
LOVASTATIN IN COMBINATION WITH ATRA PARTIALLY OVERCOMES THE BLOCK IN ATRA RESPONSIVENESS OF THE SERUM INDEPENDENT HL60 CELL LINE
IDENTIFICATION OF TRANSCRIPTION FACTORS EXPRESSED DURING ATRA AND VITAMIN D3 INDUCED NEUTROPHIL DIFFERENTIATION OF HL60 CELLS
A MALE-SPECIFIC HLA ASSOCIATION IN CHILDHOOD LEUKAEMIA
IDENTIFICATION OF PML/RAR alpha REARRANGEMENTS IN SUSPECTED ACUTE PROMYELOCYTIC LEUKAEMIA (APL) USING IN SITU HYBRIDISATION ON BONE MARROW (BM) SMEARS
LRP OVER-EXPRESSION AND INCREASED PGP FUNCTION IN ACUTE MYELOID LEUKAEMIA (AML) CELLS PREDICT A POOR RESPONSE TO CHEMOTHERAPY AND REDUCED PATIENT SURVIVAL
SURVIVAL FROM ACUTE LEUKAEMIA IN PATIENTS OVER 55 YEARS IN N.IRELAND
HEAT SHOCK PROTEINS AND CHEMORESISTANCE IN HUMAN LEUKAEMIC CELLS
PREVENTION OF RECURRENT FUNGAL PNEUMONIA WITH LOW DOSE AMPHOTERICIN B LIPID COMPLEX (ABELCET) IN IMMUNOCOMPROMISED PATIENTS
EXAMINATION OF HOX GENE EXPRESSION IN TWO HUMAN LEUKAEMIC CELL LINES, TF-1 AND UT7
DETECTION OF 11Q23 TRANSLOCATIONS BY NESTED RT-PCR- MRD ANALYSIS USING HOT PCR SHOWS INCREASED SENSITIVITY
ANALYSIS OF THE EXPRESSION LEVEL OF NORMAL AML1 AND MTG8 GENES IN NORMAL HAEMOPOETIC CELLS AND IN ACUTE MYELOID LEUKAEMIA BY SEMI-QUANTITATIVE RT-PCR
DETECTION OF PML-RAR alpha TRANSCRIPTS IN ACUTE PROMYELOCYTIC LEUKAEMIA BY IN-CELL RT-PCR
ANALYSIS OF GENE EXPRESSION PRODUCED BY THE EXPOSURE OF NB4 APL CELL LINE TO ATRA AND alpha-INTERFERON BY DIFFERENTIAL DISPLAY TECHNIQUE
FUNCTIONAL CHARACTERIZATION OF THE MLL GENE PROMOTER
ABNORMALITIES OF THE ETV6 GENE OCCUR IN THE MAJORITY OF PATIENTS WITH ABERRATIONS OF THE SHORT ARM OF CHROMOSOME 12
FISH CONFIRMS NEW TRANSLOCATION PARTNERS FOR THE MLL GENE AT 6q13 AND 17p13 IN ACUTE LEUKAEMIA
BIALLELIC REARRANGEMENTS OF THE SHORT ARM OF CHROMOSOME 12 IN ACUTE LYMPHOBLASTIC LEUKEMIA
FISHING IN ALL97
THE USE OF LIPOSOMAL AMPHOTERICIN B AS A LOADING DOSE IN THE TREATMENT OF SUSPECTED FUNGAL INFECTIONS IN NEUTROPENIC PATIENTS
RETINOIC ACID RECEPTOR ALPHA (RAR alpha) GENE REARRANGEMENTS IN NON-ACUTE PROMYELOCYTIC LEUKAEMIA (NON-APL)
TEL/ETV6 IS INFREQUENTLY ALTERED IN CHRONIC LYMPHOCYTIC LEUKEMIA
EARLY UP-REGULATION OF BAX IS A PRE-REQUISITE FOR CHLORAMBUCIL-INDUCED CELL DEATH IN B-CLL
COMBINATION THERAPY WITH FLUDARABINE AND CYCLOPHOSPHAMIDE AS SALVAGE TREATMENT IN LYMPHOPROLIFERATIVE DISORDERS
TNF alpha -INDUCED APOPTOSIS IN HUMAN LEUKAEMIC CELLS CAN BE INHIBITED BY AN INHIBITOR OF ICE AS WELL AS BY INHIBITORS OF CPP32 (CASPASE 3)
SPONTANEOUS APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) IS INHIBITED BY HOMOTYPIC CELL-CELL CONTACT INVOLVING A SIALIC ACID-CONTAINING LIGAND
THE EXPRESSION AND CONTROL OF MATRIX METALLOPROTEINASES (MMPs) IN MATURE MALIGNANT B CELLS
CLL-CELL MOTILITY
FDG-PET SCANNING AND POST-CHEMOTHERAPY RESIDUAL MASS IN LYMPHOMA
CYCLOPHOSPHAMIDE, CYTOSINE ARABINOSIDE, IDARUBICIN AND METHYLPREDNISOLONE (CAIP) AS A DEBULKING REGIMEN PRIOR TO STEM CELL MOBILISATION IN RELAPSED/REFRACTORY LYMPHOMAS
ISOLATION AND CHARACTERISATION OF NOVEL GENES FROM HUMAN CHROMOSOMAL REGION 13Q14 FREQUENTLY DELETED IN CHRONIC LYMPHOCYTIC LEUKAEMIA
G-IVE SALVAGE THERAPY FOR RELAPSED LYMPHOMA RESULTS IN HIGH RESPONSE RATES AND ALLOWS RAPID PROGRESSION TO HIGH-DOSE THERAPY
EPIC AS A LOW TOXICITY CONDITIONING REGIMEN FOR RELAPSING LYMPHOMA PRIOR TO PBSCT
LOW GRADE T CELL MALIGNANCY ANALYZED BY TRIPLE MARKER ANALYSIS OF NORMAL VERSUS ABERRANT PATTERNS ON FLOW CYTOMETRY
SEROLOGICAL SIMILARITIES BETWEEN HYPER-REACTIVE MALARIAL SPLENOMEGALY AND TROPICAL SPLENIC LYMPHOMA
STUDIES ON THE P53 GENE AND PROTEIN EXPRESSION IN SEZARY SYNDROME (SS) AND T-PROLYMPHOCYTIC LEUKAEMIA (T-PLL)
IN PATIENTS WITH LYMPHOMA RECOVERING FROM AUTOIMMUNE COMPLICATIONS OF FLUDARABINE, RELAPSE MAY BE TRIGGERED BY CONVENTIONAL CHEMOTHERAPY
THE USE OF IMMUNOGLOBULIN HEAVY CHAIN VARIABLE REGION GENES IN CHRONIC LYMPHOCYTIC LEUKAEMIA
ACTIVATION OF SOMATIC MUTATION IN A NEOPLASTIC B-CELL CLONE EMERGING AT A TISSUE SITE DURING A LATE STAGE OF DISEASE
SOMATIC HYPERMUTATION OF VH GENES IN "MANTLE CELL LEUKAEMIA"
THE USE OF FISH TO DELINEATE STRUCTURAL ABNORMALITIES OF CHROMOSOME 11q in CLL
GENETIC ANALYSIS OF SPLENIC LYMPHOMA WITH VILLOUS LYMPHOCYTES USING COMPARATIVE GENOMIC HYBRIDISATION AND FLUORESCENT IN SITU HYBRIDIZATION
RESPONSIVENESS TO CD40 MONOCLONAL ANTIBODIES AND CLINICAL STAGE OF B-CLL
INCREASED CANCER INCIDENCE AMONG RELATIVES OF PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
EXPANSIONS OF CLONAL CD4+ T CELLS IN PATIENTS WITH B-CLL EXHIBIT PROPERTIES OF 'T-NK' CELLS
CAMPATH1H THERAPY FOR PATIENTS WITH REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL)
IDENTIFICATION OF TRANSFORMED FOLLICLE CENTRE CELL LYMPHOMAS USING CD10, BCL-2, AND CDw75
THE PROMYELOCYTIC LEUKEMIA ZINC FINGER (PLZF) TRANSCRIPTION FACTOR IS DEREGULATED IN CHRONIC LYMPHOCYTIC LEUKEMIA
ECONOMIC IMPACT OF USING CLODRONATE IN THE MANAGEMENT OF PATIENTS WITH MULTIPLE MYELOMA
BONE MINERAL TURNOVER FOLLOWING HIGH DOSE CHEMOTHERAPY AND AUTOGRAFTING IN MULTIPLE MYELOMA
ALLOGENEIC TRANSPLANTATION FOR MULTIPLE MYELOMA - EVIDENCE FOR LONG TERM MOLECULAR REMISSIONS
DETECTION OF TUMOUR CONTAMINATION IN PBSC HARVESTS IN MULTIPLE MYELOMA USING MOLECULAR AND FLOW CYTOMETRIC METHODS
IMMUNOGLOBULIN IMMUNOSTAINING SHOULD BE AN INTEGRAL PART OF THE INVESTIGATION OF PARAPROTEINAEMIAS
A BACTERIAL TOXIN, VEROCYTOTOXIN, INDUCES APOPTOSIS IN MYELOMA CELL LINES
CHARACTERISATION AND ISOLATION OF TRANSLOCATIONS INVOLVING THE IMMUNOGLOBULIN HEAVY CHAIN LOCUS IN MULTIPLE MYELOMA
THE DEGREE OF BLOOD AND MARROW PLASMA CELL INFILTRATION DEPEND ON CD56 EXPRESSION
CHROMOSOMAL ABNORMALITIES IN PLASMA CELLS ARE NOT PRESENT WITHIN THE B CELL POPULATION
ANEUPLOIDY IN MULTIPLE MYELOMA USING DUAL COLOUR FISH
QUALITY OF LIFE IN MULTIPLE MYELOMA
CISPLATIN, HIGH DOSE CYTOSINE AND DEXAMETHASONE (DHAP) AS A PBSC MOBILISATION REGIME IN PLASMA CELL MYELOMA
EFFECTS OF INTERFERON-ALPHA ON CULTURED ERYTHROID PROGENITORS FROM CDA TYPE I
THE SIGNIFICANCE OF INCREASED NUMBERS OF HYPERCHROMIC RED CELLS
SUCCESSFUL USE OF COIL EMBOLIZATION TO TREAT CEREBRAL ANEURYSMS IN PATIENTS WITH SICKLING DISORDERS
INTERETHNIC VARIATION IN PREVALENCE OF MUTATION WITHIN FUNCTIONAL ELEMENTS OF THE TRIOPHOSPHATE ISOMERASE GENE PROMOTER
PROSPECT FOR ENZYME REPLACEMENT THERAPY IN A RED CELL ENZYMOPATHY
G6PD-BRIGHTON
SEQUENTIAL ASSESSMENT OF OXIDANT STRESS AND CLINICAL SEVERITY DURING A SICKLE CELL CRISIS
SICKLE CELL DISEASE AND NITROUS OXIDE INDUCED NEUROPATHY
DUFFY ANTIGEN MATCHING AT ONSET IN PATIENTS WITH SEVERE HAEMOGLOBINOPATHIES
NON-TRANSFERRIN BOUND IRON (NTBI) IN SICKLE CELL DISEASE AND CONTROL PATIENTS
PNEUMOCOCCAL AND HAEMOPHILUS ANTIBODY STATUS OF ADULT SICKLE CELL PATIENTS AND THEIR RESPONSE TO IMMUNISATION
PULMONARY FUNCTION TESTS IN SICKLE CELL DISEASE (SCD) PATIENTS DO NOT ALWAYS DETERIORATE WITH TIME
RESPONSE TO BIPHOSPHONATE THERAPY FOR OSTEOPOROSIS IN THALASSAEMIA MAJOR
IDENTIFICATION OF NOVEL HAEMOGLOBIN VARIANTS Hb HACKNEY alpha27 (Glu [arrow right] Ala), Hb St MARY'S beta101 (Glu [arrow right] Ala) BY MASS SPECTROMETRY
Evaluation of A New Flow Cytometric Method for Measurement of Foetal Haemoglobin Containing Reticulocytes (F-Retics)
UP-REGULATION OF Fc gamma RI AND ITS ROLE IN RED CELL DESTRUCTION IN THALASSAEMIA
PRESERVATION OF INR SPECIMENS USING POLYPROPYLENE COLLECTION TUBES
VARIATION IN ISI AND MNPT DETERMINATION
IS VON WILLEBRAND FACTOR A DETERMINANT OF PLASMA VISCOSITY?
EFFECTS OF INFLUENZA VACCINATION ON THE BLOOD COUNTS OF PEOPLE AGED OVER 65
USING THE TAIPAN SNAKE VENOM ASSAY ROUTINELY TO ASSESS LUPUS ANTICOAGULANT STATUS IN ANTICOAGULATED PATIENTS
FLOW CYTOMETRY ALTERNATIVE TO THE KLEIHAUER TEST
QUALITY CONTROL OF UNFRACTIONATED HEPARIN IN PATIENTS WITH ISCHAEMIC HEART DISEASE
VARIATION IN COAGULATION FACTORS
Comparative Study of Five Commercial Reagents for Preparing Leucocytes for Immunophenotypic Analysis by Flow Cytometry
PLATELET AND ENDOTHELIAL ACTIVATION FOLLOWING STREPTOKINASE FOR ACUTE MYOCARDIAL INFARCTION
THE VALIDITY OF TISSUE FACTOR ASSAYS AS A DIAGNOSTIC TOOLS FOR CANCER
CLINICAL EVALUATION OF ORAL ANTICOAGULANT MONITORING WILL THE TAS NEAR PATIENT TEST SYSTEM
THE SENSITIVITY AND SPECIFICITY OF REAGENTS FOR LUPUS ANTICOAGULANT TESTING VARY BETWEEN PHOTO-OPTICAL AND MECHANICAL COAGULOMETERS
THE BCSH / MDA STUDY OF COMMERCIAL FIBRINOGEN REFERENCE PREPARATIONS
THE INFLUENCE OF TARGET PROTEIN HALF-LIFE ON THE EFFECTIVENESS OF ANTISENSE OLIGONUCLEOTIDES
COMPARISON OF STREPTOLYSIN-O PERMEABILISATION, ELECTROPORATION AND LIPOPHILIC CONJUGATION FOR DELIVERING ANTISENSE OLIGONUCLEOTIDES TARGETING BCR-ABL
DOWNREGULATION OF THE HUMAN CATALYTIC SUBUNIT GENE OF TELOMERASE, HTRT, IS CONCOMITANT WITH TELOMERASE SUPPRESSION DURING LEUKAEMIC DIFFERENTIATION
FUNCTIONAL BCR-ABL DOES NOT PROTECT MDR-1 POSITIVE K562 CELLS FROM DRUG INDUCED APOPTOSIS
CYCLIC AMP-DEPENDENT PROTEIN KINASE ACTIVITY IS ASSOCIATED WITH THE SUSCEPTIBILITY TO ETOPOSIDE INDUCED APOPTOSIS IN MULTIDRUG-RESISTANT HUMAN K562 LEUKEMIC CELLS
FAMILIAL OCCURRENCE OF PROGRESSIVE MASTOCYTOSIS
THE METHODS OF EX-VIVO CULTURE OF PERIPHERAL BLOOD STEM CELLS FROM PATIENTS WITH CHRONIC GRANULOCYTIC LEUKAEMIA (CGL) ALTERS THE LEVEL OF BCR-ABL GENE EXPRESSION
CML PATIENTS WHO RELAPSE FOLLOWING BMT SHOW NON-RANDOM INVOLVEMENT OF CHROMOSOME 13
COMPREHENSIVE GENETIC ANALYSIS OF CML BLAST CRISIS USING 24 COLOUR PAINTING AND CGH
CHROMOSOME 9 DELETIONS ACCOMPANY BOTH STANDARD AND VARIANT Ph TRANSLOCATIONS
DIFFERENTIAL RESPONSIVENESS OF CML AND NORMAL HAEMOPOIETIC PROGENITOR CELLS TO MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (MIP-1 alpha)
CHARACTERISATION OF TRYPTASE POSITIVE CELLS DERIVED FROM THE HUMAN PHILADELPHIA POSITIVE LEUKAEMIA CELL LINE KU812. A MODEL FOR STUDYING MAST CELLS
OVEREXPRESSION OF HSP70 IN HUVEC CELLS USING AN ADENOVIRUS VECTOR IS PROTECTIVE AGAINST APOPTOSIS INDUCED BY EITHER BCNU OR TNF-alpha AND CYCLOHEXIMIDE
MONOCYTE ANERGY IN SEPTIC SHOCK IS ASSOCIATED WITH SPONTANEOUS AND ACTIVATION-INDUCED APOPTOSIS
T CELL CYTOKINE PROFILES AND DEEP SEATED FUNGAL INFECTION IN PATIENTS WITH ACUTE LEUKAEMIAS
THE PRODUCTION OF ERYTHROPOIETIN DEPENDS ON MULTIPLE OXYGEN SENSING PATHWAYS
ISOLATION AND CHARACTERISATION OF THE FUGU STEM CELL LEUKAEMIA (SCL) GENE
EVALUATION OF THE TAGUCHI METHOD FOR DETERMINING THE EFFECT OF MULTIPLE VARIABLES ON LEUKAEMIC CELL SURVIVAL
RECOMMENDATIONS ON THE USE OF COLONY STIMULATING FACTORS (CSF) IN CHILDREN - CONCLUSIONS OF A EUROPEAN PANEL
THE IN VITRO EFFECT OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR ON MEGAKARYOPOIESIS IN PATIENTS WITH APLASTIC ANAEMIA
LOW DOSE G-CSF (LENOGRASTIM) IS COST-EFFECTIVE IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES AFTER PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
ADULT FAMILIAL MYELODYSPLASTIC SYNDROMES (f-MDS)
REFRACTORY ANAEMIA WITH ISOLATED del(16)(q22q24)
MEGAKARYOPOIESIS IN MYELODYSPLASTIC SYNDROMES
M-FISH IN HAEMATOLOGICAL MALIGNANCIES
9-CIS-RETINOIC ACID TREATMENT FOR MYELODYSPLASIA
5-AZA-2'-DEOXYCYTIDINE IN MYELODYSPLASIA
MOLECULAR BASIS FOR VARIABLE CLINICAL EXPRESSION OF WISKOTT-ALDRICH SYNDROME
SEVERE CHRONIC NEUTROPENIA
NEONATAL HAEMOLYTIC ANAEMIA DUE TO DE NOVO gamma delta betao THALASSAEMIA ASSOCIATED WITH INTACT STRUCTURAL GLOBIN GENES
THIOGUANINE VERSUS MERCAPTOPURINE FOR THERAPY OF CHILDHOOD LYMPHOBLASTIC LEUKAEMIA
IMPROVED OUTCOME FOR UNRELATED DONOR (UD) BMT IN CHILDREN NOW COMPARES WITH MATCHED FAMILY DONOR (MFD) BMT
ANALYSIS OF CHIMERISM IN CHILDREN WITH HAEMOGLOBINOPATHIES UNDERGOING STEM CELL TRANSPLANTATION
LOSS OF HETEROZYGOSITY, MICROSATELLITE INSTABILITY, AND GENETIC VARIATION AT THE MLL LOCUS IN CHILDHOOD AND INFANT LEUKAEMIA
THE ROLE OF PROTEIN C REPLACEMENT THERAPY IN MENINGOCOCCAEMIA
THE PROTHROMBIN 20210A ALLELE IS NOT A RISK FACTOR FOR MYOCARDIAL INFARCTION (MI)
HETEROZYGOSITY FOR PROTHROMBIN (PT) G20210A AND FACTOR V LEIDEN (FVL) ARE GENETIC RISK FACTORS FOR VENOUS THROMBOEMBOLISM (VTE) WHEREAS HOMOZYGOSITY FOR THE METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) C677T VARIANT IS NOT
Pro2063Ser MUTATION IN VON WILLEBRAND FACTOR RESULTS IN IMPAIRED INTRACELLULAR TRANSPORT AND SECRETION
MUTATIONS IN THE PRO-PEPTIDE OF VWF CAUSING TYPE 1 AND TYPE 3 VWD
Identification of endothelial cell antigens in primary APS using a HUVEC cDNA library
SENSITIVITY OF SCREENING TESTS TO FACTOR XIII DEFICIENCY
SULPHATED LOW MOLECULAR WEIGHT HEPARIN IS A POTENT INHIBITOR OF INTRINSIC TENASE AND PROTHROMBINASE
THE INCIDENCE OF LYMPHOMA IN THE UK HAEMOPHILIA POPULATION OVER A 20 YEAR PERIOD
ALTERNATIVE DONOR BMT FOR ACQUIRED APLASTIC ANAEMIA (SAA) 1986-1993
HLA MISMATCHING AND CLINICAL OUTCOME AFTER UNRELATED DONOR (UD) BMT IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA
IMPACT OF RECIPIENT CMV STATUS ON OUTCOME AFTER T-DEPLETED VOLUNTEER UNRELATED DONOR (VUD) TRANSPLANTATION FOR CML
LOW INCIDENCE OF GVHD USING DONOR LYMPHOCYTE INFUSIONS (DLI) WITH AN ESCALATING DOSE PROTOCOL
RECOVERY OF PERIPHERAL BLOOD DENDRITIC CELLS FOLLOWING MYELOABLATIVE THERAPY AND AUTOLOGOUS STEM CELL TRANSPLANT
EXPRESSION OF CD40L ON CORD BLOOD CD4/CD8 NAIVE AND MEMORY MONONUCLEAR CELLS
AUTOGRAFTING IN SEVERE ACTIVE RHEUMATOID ARTHRITIS (RA) - MOBILISATION AND DOSE ESCALATION STUDIES
AUTOLOGOUS TRANSPLANTATION FOR YOUNGER PATIENTS WITH CLL
ANAEMIA DURING PREGNANCY AS A RISK FACTOR FOR IRON-DEFICIENCY ANAEMIA IN INFANCY
INVESTIGATION OF MITOMYCIN C INDUCED CELL CYCLE ARREST IN DYSKERATOSIS CONGENITA CELL LINES
VZV ASSOCIATED PULMONARY EMBOLISM
ANEUPLOIDY IN CHILDHOOD ALL IS NOT RELATED TO APOPTOTIC CELL FRACTION AS ASSESSED BY QUANTITATIVE ANALYSIS OF RESULTS OF DNA IN SITU LABELLING
THE PROLIFERATION FRACTION IN CHILDHOOD ALL CELLS IS RELATED TO PLOIDY STATUS - KARYOTYPE IF CORRECTED FOR OVERALL APOPTOTIC PATHWAY COMMITMENT
INTENSIFICATION OF PRE TRANSPLANT CONDITIONING IN HIGH RISK CHILDHOOD LEUKAEMIA
ADOPTIVE IMMUNOTHERAPY FOR EXTRAMEDULLARY RELAPSE OF INFANTILE ACUTE LYMPHOBLASTIC LEUKAEMIA POST BONE MARROW TRANSPLANTATION
EX VIVO EXPANSION OF PRETERM CORD BLOOD
UNTREATED THROMBOCYTOPENIA AND LUMBAR PUNCTURE - RELATED BLEEDING RISK AT DIAGNOSIS OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL)
MOLECULAR MARKERS IN THE MANAGEMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
PROPHYLAXIS IN SEVERE HAEMOPHILIACS AND THE USE OF RIGHT ATRIAL CATHETERS
RESULTS OF A RANDOMISED DOUBLE BLIND DOSE RANGING STUDY OF LENOGRASTIM (rHuG-CSF) FOR THE MOBILISATION OF PBSC IN CHILDREN WITH SOLID TUMOURS
EXCLUSION OF ORGANIC ACID DISORDERS IN CHILDREN WITH CHRONIC IDIOPATHIC NEUTROPENIA
TOPICAL GM-CSF IN THE TREATMENT OF CERVICOFACIAL LYMPHADENITIS DUE TO MYCOBACTERIUM AVIUM INTRACELLULARE [MAI],
WISKOTT ALDRICH SYNDROME PRESENTING AS ISOLATED THROMBOCYTOPENIA
THE ROLE OF CONGENITAL THROMBOPHILIA IN PAEDIATRIC THROMBOSIS
NATURAL ANTICOAGULANT PROTEINS IN PORTAL VEIN THROMBOSIS
ENDOTHELIAL DYSFUNCTION AND PLATELET ACTIVATION IN CHRONIC ATRIAL FIBRILLATION
WARFARIN INDUCTION
2 YEARS EXPERIENCE OF OUTPATIENT TREATMENT OF DEEP VEIN THROMBOSIS
APPLICATION OF A NOVEL AND RAPID WHOLE BLOOD ESTIMATION OF D-DIMERS TO SCREEN FOR DEEP VEIN THROMBOSIS IN THE A & E DEPARTMENT
A COMPARISON OF ABDOMINAL AND LAPAROSCOPIC HYSTERECTOMY ON COAGULATION MARKERS
OCCURRENCE OF ADDITIONAL THROMBOPHILIC ABNORMALITIES IN INDIVIDUALS WITH FV LEIDEN
POSTER WITHDRAWN
PROTHROMBIN GENE MUTATION & THIRD GENERATION ORAL CONTRACEPTIVES - A CASE REPORT OF A COELIAC AXIS THROMBOSIS & SPLENIC INFARCTION
FACTOR XII ANTIBODIES IN LUPUS ANTICOAGULANT POSITIVE PATIENTS
PLATELET AND PLASMA PAI-1 ANTIGEN AND ACTIVITY IN PATIENTS AT RISK OF THROMBOSIS; STUDIES ON CORONARY ARTERY DISEASE AND ESSENTIAL THROMBOCYTHAEMIA
DISORDERED FIBRINOLYSIS IN KLINEFELTER'S SYNDROME
INCREASED SOLUBLE P-SELECTIN PREDICTS DISEASE PROGRESSION IN PERIPHERAL ATHEROSCLEROSIS
A WHOLE BLOOD, MULTIPLEX DETECTION METHOD FOR FACTOR V LEIDEN AND THE PROTHROMBIN G20210A VARIANT
LOCAL CALIBRATION OF THROMBOPLASTIN/INSTRUMENT SYSTEMS FOR INTERNATIONAL NORMALISED RATIO (INR) DETERMINATION
CLINICALLY IMPORTANT DIFFERENCES BETWEEN ANTI Xa ASSAY RESULTS DURING LOW MOLECULAR WEIGHT HEPARIN OR DANAPAROID THERAPY
IS THE EPITOPE OF ANTIPHOSPHOLIPID ANTIBODIES IN THOSE WITH PREGNANCY LOSS DIFFERENT TO THAT CAUSING THROMBOSIS?
TISSUE LOCALISATION OF CELLULAR REACTIVITY OF AUTOANTIBODIES ON AORTA, CAROTID AND CORONARY ARTERIES
RETINAL VEIN THROMBOSIS IN SUBJECTS < 55 YEARS OF AGE
THROMBOSIS, MARKERS OF THROMBOTIC RISK, INDWELLING CENTRAL VENOUS CATHETERS AND EFFICIENCY OF ANTITHROMBOTIC PROPHYLAXIS USING LOW-DOSE WARFARIN
PARTICULATE AIR POLLUTION AND CARDIOVASCULAR RISK
ACQUIRED APC RESISTANCE AND PREGNANCY OUTCOME
SIGNIFICANT BED SAVINGS RESULTING FROM OUTPATIENT MANAGEMENT OF DVT WITH LMWH
THE INCIDENCE AND SIGNIFICANCE OF ANTI-beta 2 GLYCOPROTEIN 1 (beta 2GPI) ANTIBODIES IN PATIENTS WITH ANTI-PHOSPHOLIPID ANTIBODIES
A LONGITUDINAL STUDY OF THE RELATIONSHIP BETWEEN LIPID, HAEMOSTATIC AND HORMONAL CHANGES DURING NORMAL PREGNANCY
OUTPATIENT TREATMENT OF DEEP VEIN THROMBOSIS USING LOW MOLECULAR WEIGHT HEPARIN
PREVALENCE OF ANTIPHOSPHOLIPID ANTIBODIES (aPL) IN INFERTILE WOMEN REFERRED FOR IN-VITRO FERTILISATION (IVF)
ASSOCIATION OF TOTAL AND FREE PROTEIN S ANTIGEN WITH SERUM LIPIDS
THE EFFECTS OF ACUTE HYPERHOMOCYSTEINAEMIA ON PLATELET ACTIVATION AND PAI-1
CORRELATION OF FVIII LEVELS WITH PROTHROMBIN FRAGMENTS1+2 AND THROMBIN ANTITHROMBIN COMPLEXES IN 44 PATIENTS WITH VENOUS THROMBOEMBOLISM
ELEVATED FACTOR VII
Hirudo medicinalis for limb-threatening venous congestion in patient on Warfarin
TOWARDS GENE THERAPY FOR HAEMOPHILIA B
MOLECULAR BASIS OF TWO FAMILIAL CASES OF FEMALE HAEMOPHILIA B
PROTEASE INHIBITOR THERAPY IN HIV INFECTED HAEMOPHILIC PATIENTS
EPIDEMIOLOGY OF EPSTEIN-BARR VIRUS INFECTION IN HIV INFECTED HAEMOPHILIC PATIENTS
TREATMENT OF HEPATITIS C (HCV) INFECTION IN PATIENTS WITH BLEEDING DISORDERS USING AN INTERFERON (IFN) / RIBAVIRIN (RBV) COMBINATION
THROMBOTIC RISK FACTORS ASSOCIATED WITH TRANSURETHRAL PROSTATECTOMY
ALTERATIONS IN HAEMOSTATIC PARAMETERS FOLLOWING TRANSURETHRAL PROSTATECTOMY
RECOMBINATE PUP MUTATION STUDY
FACTOR VIII INHIBITORS IN HAEMOPHILIA PATIENTS AT THE KATHARINE DORMANDY HAEMOPHILIA CENTRE OVER A 34 YEAR PERIOD, (1964-1997)
CONTINUOUS FIX INFUSION [MONONINE] FOR ORTHOTOPIC LIVER TRANSPLANTATION
MOLECULAR MODELLING OF LIGAND AND MUTATION SITES OF THE A1 AND A2 DOMAINS OF HUMAN VON WILLEBRAND FACTOR AND THEIR RELEVANCE TO VON WILLEBRAND'S DISEASE
PREGNANCY IN PATIENTS WITH VON WILLEBRAND'S DISEASE OR FACTOR XI DEFICIENCY
DIAGNOSIS AND RECLASSIFICATION OF TYPE 1 VWD
USE OF THE ABI PRISM [trade mark sign] GENETIC ANALYZER FOR THE IDENTIFICATION OF MUTATIONS IN PATIENTS AND CARRIERS OF HAEMOPHILIA A
VARIATION IN CLINICAL SEVERITY OF HAEMOPHILIA A IN INDIVIDUALS WITH THE SAME FVIII MUTATION
A NOVEL 8 BASE DELETION IN EXON 51 OF VWF GENE COULD BE THE CAUSE OF A IID PHENOTYPE OF VON WILLEBRAND DISEASE
ANTICOAGULANT INDUCED INTRACRANIAL HAEMORRHAGE
TWO UNRELATED FAMILIES WITH DIFFERENT TYPE 2N VWD MUTATIONS SHARE A COMMON SPLICE SITE MUTATION
SUCCESSFUL USE OF PROTEASE INHIBITORS IN HIV-INFECTED PATIENTS WITH HAEMOPHILIA
A COMPARISON OF CONTINUOUS AND INTERMITTENT INFUSION OF FVIII CONCENTRATES IN HAEMOPHILIA A PATIENTS UNDERGOING SURGERY
IDENTIFICATION OF THE FACTOR VII ARG304GLN MUTATION IN AN IRANIAN POPULATION WITH FACTOR VII DEFICIENCY
CLINICAL MANIFESTATIONS OF INHERITED FACTOR X DEFICIENCY IN 32 IRANIAN PATIENTS
THROMBOPOIETIN (TPO) LEVELS IN CIRRHOSIS AND PRE/POST ORTHOTOPIC LIVER TRANSPLANTATION (OLT)
FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) AS A DIRECT METHOD FOR THE EPITOPE-SPECIFIC CHARACTERISATION OF ANTI-PLATELET ANTIBODIES
MEASUREMENT OF PLATELET ACTIVATION ON THE ADVIA 120 HAEMATOLOGY SYSTEM
PRELIMINARY CHARACTERISATION OF A NOVEL PLATELET SUBSTITUTE, SYNTHOCYTES [trade mark sign], FOR THE TREATMENT OF THROMBOCYTOPENIA
A COMPARISON OF LABORATORY TESTS FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
TAHINI ASSOCIATED THROMBOCYTOPENIA
THE PFA-100 [trade mark sign] SYSTEM
EVALUATION OF THE PFA-100 [trade mark sign] IN PATIENTS WITH SUSPECTED PLATELET DISORDERS
LAPAROSCOPIC SPLENECTOMY
THE USE OF CD34 COUNTS TO PREDICT THE SUCCESS OF STEM CELL COLLECTIONS
POSTER WITHDRAWN
HIGH-DOSE ETOPOSIDE WITH GRANULOCYTE COLONY-STIMULATING-FACTOR FOR MOBILISATION OF PERIPHERAL BLOOD PROGENITOR CELLS
ANTISENSE OLIGONUCLEOTIDES TARGETING BCR-ABL FOR PURGING AUTOGRAFTS IN CHRONIC MYELOID LEUKAEMIA
EFFECTIVE MOBILISATION OF PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH HIGH-RISK PRIMARY BREAST CANCER FOLLOWING ADJUVANT CHEMOTHERAPY (FEC) AND G-CSF
PLASTIC ADHERENT HAEMOPOIETIC PROGENITOR CELLS IN STEM CELL HARVESTS AND UMBILICAL CORD BLOOD
CYCLOPHOSPHAMIDE METABOLISM IN CHILDREN WITH FRANCOLI'S ANAEMIA
THE SYSMEX SE9000 IMMATURE MYELOID INDEX AND R2000 RETICULOCYTE PARAMETERS TO OPTIMISE TIMING OF STEM CELL HARVEST
THE VALUE OF CD34 IN MONITORING PERIPHERAL BLOOD STEM CELL HARVESTS
POTENTIAL USE OF p53 POINT MUTATIONS AS MARKERS FOR MINIMAL RESIDUAL DISEASE (MRD) DETECTION IN THE BREAST CANCER MODEL
PERIPHERAL BLOOD PROGENITOR CELLS (PBPC) HARVESTS IN MULTIPLE MYELOMA
PERFORMANCE STATUS AT PRESENTATION PREDICTS FOR SURVIVAL AFTER AUTOLOGOUS PERIPHERAL BLOOD PROGENITOR CELL (PBPC) TRANSPLANTATION IN MULTIPLE MYELOMA
INTRAVENOUS GLUTAMINE DIPEPTIDE IS ABLE TO RESTORE PLASMA GLUTAMINE LEVELS AND PROTECT AGAINST LIVER INJURY DURING HIGH DOSE CHEMOTHERAPY
WHAT FACTORS PREDICT THE YIELD OF CD34+ CELLS FROM HLA IDENTICAL SIBLING DONORS?
HAEMATOLOGICAL AND IMMUNOLOGICAL CHANGES IN SIBLING ALLOGENEIC PERIPHERAL BLOOD PROGENITOR CELL (PBPC) DONORS
A COMPARISON OF TWO DIFFERENT SYSTEMS FOR CD34+ SELECTION OF AUTOLOGOUS OR ALLOGENEIC PERIPHERAL BLOOD STEM CELL COLLECTIONS
LATE EMERGENCE OF CLONAL HOST CD 8+ LYMPHOCYTES FOLLOWING MATCHED UNRELATED DONOR BMT FOR T-ALL
THE POST G-CSF WHITE CELL COUNT IS PREDICTIVE FOR SUBSEQUENT APHERESIS PROGENITOR YIELDS
POSTER WITHDRAWN
T-CELL DEPLETION AND STEM CELL RECOVERY USING CAMPATH MONOCLONAL ANTIBODIES (MAbs) IN G-CSF MOBILISED PERIPHERAL BLOOD STEM CELLS (PBSC); COMPARISON WITH BONE MARROW (BM)
AUTOGRAFTING FOR AL AMYLOIDOSIS
VARIABLES AFFECTING UMBILICAL CORD BLOOD PROGENITOR/STEM CELL YIELD FOR CLINICAL TRANSPLANTATION
MYELOPOIESIS CAN BE REGULATED AT CFU-GM LEVEL
ENHANCED MEGAKARYOCYTE PRODUCTION FROM PBPC HARVESTS IN NHL COMPARED TO AML PATIENTS
RECOVERY OF SPERMATOGENESIS FOLLOWING BONE MARROW TRANSPLANTATION
PERCENTAGE OF CD34 POSITIVE CELLS PREDICTS FOR THE FREQUENCY OF LTC-IC IN PERIPHERAL BLOOD PROGENITOR CELL (PBSC) HARVESTS
MONONEURITIS MULTIPLEX IN A PATIENT WITH CHRONIC GRAFT VERSUS HOST DISEASE RESPONSIVE TO THE SEATTLE REGIME
10 YEAR SINGLE CENTRE EXPERIENCE OF AUTOLOGOUS TRANSPLANTATION FOR HODGKIN'S DISEASE
DIRECT VISUALISATION OF CMV-SPECIFIC AND H-Y-SPECIFIC CYTOTOXIC T CELLS USING FLUORESCENT HLA-PEPTIDE COMPLEXES
USE OF AN INTERNAL RIBOSOMAL ENTRY SITE TO EXPRESS TWO GENES FROM A DICISTRONIC CONSTRUCT AFTER RETROVIRAL INFECTION OF CYTOTOXIC T CELLS
THY-1+ PROGENITOR CELL NUMBERS CORRELATE WITH SUSTAINED ENGRAFTMENT FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION
SYNGENEIC BONE MARROW TRANSPLANTATION IN PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA (PNH). ERADICATION OF THE PNH CLONE AS DOCUMENTED BY FLOW CYTOMETRY
HERPESVIRUS SAIMIRI MEDIATED GENE TRANSFER INTO HUMAN HAEMOPOIETIC PROGENITOR CELLS
A COMPARISON OF THE AUTOPBSC SPECTRA APHERESIS PROCEDURE WITH THE MANUAL VERSION 5.1 SYSTEM
RELEVANCE OF NOD/SCID MOUSE MODEL OF HAEMATOPOIESIS TO CLINICAL CORD BLOOD TRANSPLANTATION
USE OF AUTOLOGOUS "BACK UP" BM/PBSC FOLLOWING AUTOLOGOUS AND ALLOGENEIC BMT - A SINGLE CENTRE EXPERIENCE AND SURVEY OF 85 EUROPEAN CENTRES
BUSULPHAN AND MELPHALAN
MINIMAL RESIDUAL DISEASE IN CLL POST AUTOLOGOUS STEM CELL TRANSPLANT
SELECTION OF CD34+ CELLS FROM CRYOPRESERVED PBPC CAN BE SIGNIFICANTLY IMPROVED BY THE ADDITION OF RECOMBINANT HUMAN DNASE (PULMOZYME [registered sign])
GENERATION OF FUNCTIONALLY COMPETENT ANTIGEN PRESENTING CELLS FROM CD34+ PROGENITORS SUITABLE FOR CLINICAL USE
INCREASED LEVELS OF THE SOLUBLE TNF RECEPTOR IN CORONARY AND PERIPHERAL ARTERY DISEASE
A NOVEL METHOD FOR MEASURING CELL SURFACE MARKER EXPRESSION ON SMALL NUMBERS OF CELLS
DUAL LABELLING OF CELLS FOR ASSESSMENT OF APOPTOTIC STATUS AND LINEAGE ANALYSIS BY FLOW CYTOMETRY
RAPID FLOW CYTOMETRIC IDENTIFICATION OF PUTATIVE CD14- AND CD64 (-) DENDRITIC CELLS IN WHOLE BLOOD
TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE IN AN IMMUNOCOMPETENT INDIVIDUAL FOLLOWING CORONARY ARTERY BYPASS GRAFTING
THE NUMBER OF RED CELL TRANSFUSION INCREASES SIGNIFICANTLY AS THE PLATELET COUNT DROPS BELOW 25
MEASUREMENT OF CYTOKINE LEVELS AND P SELECTIN EXPRESSION IN POOLED DONOR AND APHERESIS PLATELET PREPARATIONS AND THE EFFECT OF BEDSIDE FILTRATION ON THESE PARAMETERS
WHY ARE HAEMOGLOBIN F LEVELS RAISED IN HBE/beta THALASSAEMIA?
GPI-DEFICIENT CELLS (PNH PHENOTYPE) ARE PRESENT IN MOST INDIVIDUALS
IN VIVO MODELLING OF GENE SILENCING THERAPY IN HAEMATOLOGICAL MALIGNANCIES
THE ROLE OF MOLECULAR DIAGNOSIS & RESIDUAL DISEASE MONITORING IN APL
TARGETING HAEMATOPOIETIC STEM CELLS
'LOW RISK' MYELODYSPLASTIC SYNDROME (MDS) IS ASSOCIATED WITH EXCESSIVE APOPTOSIS AND AN INCREASED RATIO OF PROVERSUS ANTI- APOPTOTIC BCL-2 RELATED PROTEINS
EVALUATION OF RISK FACTORS FOR THROMBOSIS IN PATIENTS WITH ESSENTIAL THROMBOCYTHAEMIA
CONSISTENT FUSION OF A NOVEL GENE, DET, TO THE FIBROBLAST GROWTH FACTOR RECEPTOR-1 IN THE t(8;13)(p11;q12)
THE SCL GENE SPECIFIES HAEMATOPOIETIC STEM CELL AND ENDOTHELIAL DEVELOPMENT FROM EARLY MESODERM
AN ANALYSIS OF CHROMOSOME 13Q14 DELETIONS IN IDIOPATHIC MYELOFIBROSIS USING FISH AND SOUTHERN-BASED HYBRIDISATION
CYTOCHROME C INDUCES APOPTOSIS IN INTACT CELLS AND IS DOMINANT TO GROWTH SIGNALLING, APOPTOSIS SUPPRESSION AND MALIGNANT CHANGE
STABILIZED CELLULAR IMMUNOFLUORESCENT ANALYSIS (SCIFA)
PERIPHERAL BLOOD CONTAINS TWO DISTINCT LINEAGES OF DENDRITIC CELL
NITRIC OXIDE DEPENDENT MODULATION OF INFLAMMATORY CYTOKINE SECRETION IN MAMMALIAN MACROPHAGES BY INTRAVENOUS IMMUNOGLOBULIN
Large Granular Lymphocyte (LGL) Expansion in 20 HIV Infected Patients; Analysis of Immunophenotype and Clonality
INADEQUACIES IN THE POSTNATAL MANAGEMENT OF NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (NAIT) IN THE UK
IS THERE A PLACE FOR AUTOLOGOUS BLOOD TRANSFUSION IN ELECTIVE ORTHOPAEDIC SURGERY?